Details
New companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Tequipy >€3M SeedJuvena Therapeutics $33.5M Series BRanked by rounds participated in, from announcements in Jan 1, 2026 – Oct 24, 2026. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Tequipy >€3M SeedJuvena Therapeutics $33.5M Series BNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Farther $150M Series DEsper Undisclosed Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Hark $700M Series APasqal €170M Private financingNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Variational $50M Series AMesh $75M Series CNew companies 2 · Follow-on 0
Stages: Pre-seed 1, Undisclosed 1
Ripjar Undisclosed StrategicHuper Corporation $1.5M Pre-SeedNew companies 2 · Follow-on 0
Stages: Undisclosed 2
HawkEye 360 ≤$125M Revolving credit facilityVersana $43M UndisclosedNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Hellbender $12.5M SeedProfitmind $9M Series ANew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Vortex Imaging $12M UndisclosedSENAI $6.2M SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Gradiant Undisclosed Series EGridCARE $64M Series ANew companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Full-Life Technologies $150M Series D+DebtButterfly Medical $21M Series CNew companies 2 · Follow-on 0
Stages: Series C+ 2
Sigma Computing $80M Series EDeepgram $130M Series CNew companies 1 · Follow-on 1
Stages: Growth 1, Series C+ 1
Tomorrow.io $210M Series FTomorrow.io $175M Growth“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.